ICAP
VNDA icon

Independence Capital Asset Partners’s Vanda Pharmaceuticals VNDA Stock Holding History

Independence Capital Asset Partners’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-34,327
Closed -$356K – 96
2014
Q3 		$356K Buy
34,327
+5,250
+18% +$68.8K 0.05% 74
2014
Q2 		$470K Sell
29,077
-240,840
-89% -$3.21M 0.06% 71
2014
Q1 		$4.39M Buy
+269,917
New +$3.84M 0.73% 46

Other funds holding VNDA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Independence Capital Asset Partners's VNDA Position: Q4 2014 in Review

Independence Capital Asset Partners sold out of Vanda Pharmaceuticals (VNDA) in Q4 2014, closing a stake of 34,327 shares — an estimated $356K sold.

Independence Capital Asset Partners first reported a position in VNDA in Q1 2014 and held it in 3 quarters. The position peaked at $4.39M in Q1 2014. 109 funds tracked by Wall St. Rank hold VNDA as of Q4 2014.

  • Independence Capital Asset Partners reported no remaining Vanda Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • Independence Capital Asset Partners sold 34,327 Vanda Pharmaceuticals shares in Q4 2014, an estimated $356K.
  • Independence Capital Asset Partners first reported a position in Vanda Pharmaceuticals in Q1 2014 and held it in 3 quarters.
  • Independence Capital Asset Partners's Vanda Pharmaceuticals position peaked at $4.39M in Q1 2014.
  • 109 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q4 2014.

Based on Independence Capital Asset Partners's 13F filing for Q4 2014, filed 13 Feb 2015.